To characterize RNA-capsid binding sites genome-wide within mature RNA virus particles, we 14
Introduction 46
Flock House virus (FHV) is a non-enveloped, single-stranded positive-sense RNA (+ssRNA) virus 47 from the family Nodaviridae. The small bipartite genome comprising RNA 1 (3.1kb) and RNA 2 48
(1.4kb) is packaged into a 34 nm non-enveloped T=3 icosahedral virion. Only two non-structural 49 proteins are produced by FHV: the RNA-dependent RNA polymerase (RdRp) and sub-genomic 50
RNA encoded protein called B2. The B2 protein was discovered as the virus's approach to evade 51 the invertebrate anti-viral RNA silencing machinery (1, 2), which thereafter led to the discovery of 52 similar mechanisms in plant cells (3). FHV is perhaps the best studied alphanodavirus and 53 provides a powerful model system by virtue of its small genome size (4.5kb), genetic tractability 54 and ability to infect Drosophila and mosquito cells in culture and whole flies (reviewed in (4, 5) ). 55
More recently, FHV has been adapted into medical field. FHV-related vaccine developments 56 utilized either the viral particle as antibody-display system (6), or the viral RNA as trans-57 encapsidated chimeric viral vaccine platform (7) (8) (9) . 58
Both authentic virions of FHV and the related Pariacoto virus have been reconstructed by cryo-59
EM and X-ray crystallography to reveal highly ordered dodecahedral cages of RNAs (10, 11) . The 60
X-ray structure of FHV virion showed electron density at the icosahedral 2-fold axis, which was 61 modelled as an ordered RNA duplex of approximate 20 nucleotides (12). This would account for 62
1800nts (more than one third) of the viral genome, implicating a highly-ordered and specific set 63 of interactions between the viral protein capsid and the encapsidated genome. Interestingly, and 64
recombinantly expressed virus-like particles (VLPs) of FHV also exhibit a similar dodecahedral 65
RNA cage despite packaging predominantly cellular RNAs indicating that viral capsid may either 66 impose structure upon the encapsidated RNA or select for natively structured host RNAs such as 67
ribosomal RNAs (13, 14) . However, as these structures are obtained with icosahedral averaging, 68
we still do not know what regions or sequences of viral genomic RNA comprise the RNA cage. 69
Furthermore, it remains to be determined whether there exists a single RNA structure with 70 conserved topology in FHV virions, or rather an ensemble of related genomic RNA structures. 71
The FHV encapsidation process also remains largely unknown. One molecule of each RNA 1 and 72 2 is specifically encapsidated into virus particles (15), while subgenomic RNA 3 is excluded (16). 73
Several components of the capsid protein such as the arginine-rich motif and the C-terminal 74 FEGFGF motif have been demonstrated to be essential determinants of packaging specificity of 75 RNA 1, RNA 2, . It was also speculated that FHV packaging process may be in 76 close association with viral replication and/or translational events (20-23). In the virus genome, 77
one stem-loop structure in RNA 2 proximal to 5' end was demonstrated to be required for RNA 2 78 packaging (24). However, it remains unclear whether there are similar packaging sites on RNA 1 79 or 2, and how these sites interact and thus recruit capsid protein to fulfill virus encapsidation. 80
Next-generation sequencing (NGS) in combination with crosslinking techniques provides a high-81
throughput approach to study transcriptome-wide RNA-protein interactions (reviewed in (25) analog 4-thiouridine (4SU) to effectively crosslink RNA to bound proteins. The enriched 87
crosslinked RNAs result in a highly specific U to C mutation during NGS library preparation (27-88 29) , granting the ability to rapidly identify RBP and microRNA target sites on a transcriptome scale 89 (26) . 90
In an analogous fashion to PAR-CLIP, here we applied the same principles to study the interaction 91 of FHV genomic viral RNA in the context of assembled authentic virions. Unlike the complex 92 cellular micro-environment, authentic virions represent a highly simplified enclosure with few well-93 defined components (viral RNA and capsid). Therefore, we are able to screen for specific in virion 94
RNA-capsid interaction events without interference from other cellular components. Furthermore, 95 since viruses can be readily separated from other cellular components, we avoided the need of 96 immunoprecipitation for RNA recovery, and thus largely simplify PAR-CLIP methodology. This 97 method is hence named 'PAR-CL'. 98
Using FHV as a model system, PAR-CL methodology was validated by determining that the 99 increased U to C (U-C) mutation rate was highly specific to crosslink between viral RNA and 100
capsid. We noticed that the intensity of PAR-CL signals was subjected to the dose of 4SU and 101 time of incubation. Triplicated FHV PAR-CL experiments revealed significant and highly 102 consistent PAR-CL signals across genome, which implicated a clear tropism of RNA cage inside 103 capsid shell. The multiple clusters of PAR-CL sites suggest that FHV encapsidation may require 104 multiple synergetic packaging sites. DMS-MaPseq (dimethyl sulfate mutational profiling with 105 sequencing) was used to chemically probe single-stranded FHV genomic RNA in virions. We thus 106
constructed a whole genome DMS-MaPseq-imposed RNA secondary structure map for FHV. We 107 noticed RNA-capsid interaction sites favored double stranded RNA regions. Synonymous 108 mutations were designed to disrupt predicted PAR-CL sties in dsRNA regions, which resulted in 109 varied effects to virus RNA replication, propagation, and virulence. Mutations over certain PAR-110
CL sites showed evidential deficiency in RNA replication, suggesting these sites serve a 111 multifunctional role in both virus packaging and replication. This provides further evidence to 112 support that FHV packaging and replication are highly synchronized and inter-dependent events. 113
Results

114
Photoactivatable-ribonucleoside-enhanced crosslinking (PAR-CL) in virus particles 115
PAR-CLIP (Photoactivatable-Ribonucleoside-Enhanced Crosslinking and Immunoprecipitation) 116
is a well-established method for identification of RNA-protein binding sites and can provide 117 nucleotide-resolution through analysis of specific uridine to cytosine transitions that occur at the 118 site of RNA-crosslinking during cDNA synthesis (26, 30, 31) . Here, we simplified the technique 119
by applying a similar approach to purified authentic virions of RNA virus, thereby removing the 120 necessity of immunoprecipitation, and hence deriving the name "PAR-CL". A schematic of the 121 process is illustrated in Figure 1 . In PAR-CL, photoactivable nucleotide 4-thiouridine (4SU) was 122 provided to cells in culture prior to infection with Flock House virus (FHV). 4SU is rapidly taken by 123 cultured cells without significant cytotoxic effect (26, 32) . Upon infection, 4SU is randomly 124 incorporated into newly synthesized viral RNA, which is subsequently packaged into authentic 125 virus particles of FHV. Virus particles were isolated using established methods for virus 126 purification by ultracentrifugation (13). Next, purified virus particles were subjected to UV 365 nm 127 irradiation, yielding crosslinks between the thio-group of 4SU in the viral genomic RNA and amino 128 acid residues in the protein capsid shell only if they are in close proximity (32, 33) . Virus particles 129
were then disrupted by proteinase K treatment and a pool of viral RNAs with varied crosslinking 130 sites was obtained. We then generated canonical random-primed RNAseq libraries using 131
ClickSeq (34-36) for Illumina SE150 read sequencing on a MiSeq platform. 132
The raw sequencing reads were trimmed and quality filtered using cutadapt (37) and the FASTX 133 toolkit (http://hannonlab.cshl.edu/fastx_toolkit/index.html). Reads were aligned to the FHV 134 genome with Bowtie (v1.0.1) (38). The read coverage at each genomic position and the frequency 135 of each nucleotides found in the mapped reads was enumerated using samtools and the mutation 136 rates at each genomic position was calculated. 137
To validate the PAR-CL methodology, we first sought to determine if there was a substantial 138 increase in U-C mutation rate as a specific consequence of 4SU-capsid crosslink. We performed 139
a series experiments in which wild-type (wt) FHV without 4SU (4SU-) or 4SU-containing FHV 140 (4SU+) were treated with (UV+) or without (UV-) UV irradiation. As illustrated for FHV RNA 1 in 141 Figure 2a , we plot the measured U-to-C (U-C) mutation rate across the genome and calculate 142 the fold change at each U position. A small number of positions, such as nt. 1259 on RNA 1, 143
showed high U-C mutation rates in both conditions. This possibly reflects the selection of a 144 minority variant during virus passaging. Other than this, we did not notice an increased U-C 145 mutation rate for UV-irradiated FHV in the absence of 4SU (4SU-/UV+). This indicated as 146 expected that UV irradiation alone was not sufficient to induce novel U-C mutations. Similarly, we 147 measured the influence of 4SU substitution in FHV genomic RNA without UV exposure 148 (4SU+/UV-) (Figure 2b) . We also did not notice an increase in U-C mutation rate. We only 149 observed increased U-C mutations when 4SU and UV irradiation both were present (4SU+/UV+) 150 (Figure 2c) . This confirms the elevated U-C mutation rate is indeed a specific result of 4SU-151 induced crosslinking. The FHV RNA 2 data of these experiments is shown in Supplemental 152 Figure S1 . 153
Histograms of the U-C mutation rate frequencies at all genomic U positions are shown in Figure  154 2d. This demonstrated that under 4SU+/UV+ condition, more U positions exhibited high U-C 155 mutation rate (≥0.3%) than controls (4SU-/UVand 4SU+/UV-). Interestingly, we noticed reduced 156 U-C mutation rates when wt FHV was exposed to UV (4SU-/UV+), for an unknown reason. We 157 also sought to determine if 4SU incorporation and UV exposure would induce any non-specific 158
(non-U-C) mutations. A histogram of the frequencies of all non-U-C mutations (A,C,G mutations 159 and U-A, U-G mutations) over all genomic positions is shown in Figure 2e . Importantly, 160 4SU+/UV+ FHV did not show any significant change in non-U-C mutations. We therefore 161
conclude that the increased U-C mutation rate is specific to 4SU-induced crosslinking. 162
163
Magnitude of PAR-CL signals was associated with 4SU dose and incubation time. 164
Our PAR-CL method requires no immunoprecipitation to recover and enrich for crosslinked RNAs. 165 However, this permits wild type uridine and/or uncrosslinked 4-thiouridine to persist in the RNA 166 pool which may dilute the PAR-CL signal. To investigate optimum conditions for PAR-CL, we 167
conducted three parallel experiments (Figure 3) . S2 cells were infected with FHV and incubated 168
with 4SU at 100µM (4SU16h) or 150µM (4SU1.5X). Viruses were harvested from infected cells 169 16 h post-infection. In a third experiment, we extended the incubation time to 40 h, and applied 170 4SU in a "prime-boost" manner, to reach a final concentration of 200µM (4SU40h). In each 171 experiment, U-C mutation profile of 4SU+/UV+ virus was compared with correspondent 4SU+/UV-172 virus to yield PAR-CL signals (fold change). Results for FHV RNA 1 are shown in Figure 3a and 173
RNA 2 in Supplemental Figure S2 . We noticed that the concentration of 4SU and the incubation 174 time of FHV/4SU had an impact on PAR-CL signal intensities over a number of genomic U 175
positions. 176
The same results were observed when we plotted the frequency of PAR-CL signals for these 177 three experiments, as well as two controls (Figure 3b ). This shows that while the mean PAR-CL 178 signals and the distribution under all three conditions (4SU16h, 4SU1.5X, and 4SU40h) and a 179 4SU+/UV-control were all comparable, the magnitude of outliers showed correlation to 180 experimental conditions (4SU40h > 4SU1.5X > 4SU16h). This indicates that only certain 4SU 181 substitution sites are available for crosslink and therefore sensitive to the varied 4SU 182 concentrations/incubation times. Again, for an unknown reason, the 4SU-, UV+ control ( Figure  183 3b) showed a slightly lesser than 1-fold change PAR-CL signal. Importantly, this does not interfere 184 with our interpretation of PAR-CL signals in crosslinking samples. 185
We sampled the top 5% of PAR-CL signals in each conditioned experiment (Figure 3c ) and 186 concluded that, the 4SU40h group showed significantly higher PAR-CL signals than the rest. For 187 this reason, the 4SU40h experimental condition was applied to all further PAR-CL experiments, 188
unless otherwise mentioned. Despite the varied PAR-CL signal intensities under different 189 experimental conditions, the PAR-CL signals presented good Pearson's correlation coefficient 190 (≥0.6) between these parallel experiments (Supplemental Figure S3 ), which indicates high 191
reproducibility of PAR-CL experiments. 192 193
Consistent PAR-CL signals indicates structural tropism of encapsidated viral RNAs 194
We applied the 4SU40h condition in three parallel experiments: three separate S2 cell cultures 195
were incubated with virus and 4SU, and individually purified viruses were exposed to UV and 196 thereafter proceeded to sequencing. Similar to before, PAR-CL experiments were conducted in 197 pairs, with each PAR-CL dataset comprised of one crosslinked sample (4SU+/UV+) and control 198
with the same sample but without UV irradiation (4SU+/UV-). To ensure reliable mutation rate 199 calculation, we selected for U positions with coverage of at least 10,000 reads. This allowed us 200 to detect reliable mutation profiles over U34 -U3034 on RNA 1, and U9 -U1337 on RNA 2. The 201
PAR-CL signals of these three experiments were compared on each U position on viral RNA 202 genomes (Figure 4a, b) . We observed good Pearson's correlation coefficient (≥0.6) between 203 these replicates (Supplemental Figure S4) . To validate the consistent PAR-CL signals, the 204 signals over every U position were box-plotted over the triplicates (Supplemental Figure S5) . 205 This allows us to readily measure the mean signal strength and signal variation over the triplicates. 206
In order to distinguish reliable crosslinking sites and avoid potential false positives, we removed 207
any PAR-CL signals in crosslinked sample by applying a conservative background threshold filter, 208
retaining only the highest 5% of PAR-CL signals in the uncrosslinked control sample. (Figure 4c , 209 d, Supplemental data 3). Among the most consistent PAR-CL sites (passed background 210 threshold in all three replicates), we identified 20 sites in RNA 1 and 8 sites in RNA 2 that showed 211
the highest average PAR-CL signals (Figure 4e, Supplemental data 3) . T-test revealed most of 212 these sites have significantly (P<0.05) higher PAR-CL signal than average. As these same sites 213
consistently displayed significant PAR-CL signals over parallel replicates, this indicates a set of 214 consistent RNA-capsid interactions in authentic FHV virions, which further indicates a structural 215 tropism of FHV RNA in association with the topology of virus capsid shell. 216 217
Probing FHV in virion RNA secondary structures with DMS-MaPseq. 218
We sought to understand if there is any sequence motif among the PAR-CL sites. Significant (>2σ) 219
PAR-CL sites (28 sites from RNA 1 and 15 from RNA 2) and their flanking sequences were 220
analyzed with Discriminative Regular Expression Motif Elicitation (DREME, (39)) for possible 221 sequence motif identification (Supplemental Figure S6 ). However, no common motif was 222
identified. This led us to hypothesize that the mechanism of RNA recognition by FHV capsids may 223 be related to similar RNA structures rather than sequences. To reliably predict the RNA secondary 224
structures of PAR-CL signals, we sought to determine the secondary structure of FHV RNA in 225 authentic virions. 226
Dimethyl sulfate mutational profiling with sequencing (DMS-MaPseq) provides a reliable and high 227 throughput method to probe RNA secondary structures in vivo (40-42). The resulting constraints 228 provided improvement to thermodynamic map and free energy-based secondary structure 229 prediction. We performed DMS-MaPseq using the TGIRT TM -III enzyme but in combination with 230
ClickSeq to generate RNAseq libraries ("TGIRT-ClickSeq") ( Figure 5a) , demonstrating that 231
TGIRT TM -III enzyme is compatible with ClickSeq. DMS-MaPseq induces RNA modifications to 232 unpaired adenines and cysteines (and guanine to a lesser level (43)) across the viral genome. 233
Therefore, as expected, in comparison to untreated control virus (DMS-) DMS-treated FHV 234
(DMS+) has a higher average mutation rate over genomic A/C positions (Figure 5b) . Similarly, 235
we plotted the frequency of mutation rates over A/C or G/U positions and only noticed a significant 236 higher mutation rate frequency over A/C positions (Figure 5c ). We analyzed A or C positions with 237 at least 10k read coverage, which corresponds to nt. 14 -3043 on RNA 1 and nt. 11 -1378 on 238
RNA 2. Similar to PAR-CL data, DMS-MaPseq signal represents the mutation rate fold change 239
between DMS-treated virus and untreated control virus, on all genomic A or C positions. Likewise, 240
we removed potential false-positive signals by applying a background noise threshold, retaining 241
only the genomic sites with mutation rate higher than this threshold. The resulting DMS-MaPseq 242 profile of FHV (Figure 5d and e) showed clear signals up to 100-fold change over both RNA 1 243 and 2. The un-refined DMS-MaPseq profiles with background noise, and mutation rate 244 comparison between DMS-treated and untreated viruses are shown in Supplemental Figure S7 . 245
DMS-MaPseq resolved FHV RNA secondary structures reveals that PAR-CL sites favor 247
double stranded structures and are highly clustered. 248
We incorporated the DMS-MaPseq data into free energy based thermodynamic prediction, by 249
introducing a series of "soft" constraints. Only the most significant (>2σ) DMS-MaPseq sites (60 250 sites in RNA 1 and 30 sites in RNA 2) were forced as unpaired constraints in RNAstructure Web 251
Server (44) with "Fold" algorithm (44, 45) . Regardless of their DMS-MaPseq signals, the remaining 252 genome positions were left without any constraints, to allow maximum prediction flexibility. We 253 thereby constructed a DMS-MaPseq-imposed secondary structure map of complete FHV RNA 254 genome (snapshots in Figure 6 , full-scaled maps of RNA 1 and RNA 2 were also provided in 255
Supplemental data 1 and 2 unconstrained and constrained folding can be found in Supplemental Figure S8 . 261
In combination with PAR-CL data, we noticed that the significant PAR-CL sites heavily favored 262
double-stranded base-pairing. In RNA 1, among the 28 most significant (>2σ) PAR-CL sites, 22 263
are located in double-stranded regions, whereas 3 sites were 1 nt. adjacent to double-stranded 264 stems. In the much shorter RNA 2, 8/15 of most significant PAR-CL sites are located in dsRNA 265 stems, whereas 3 are 1 nt. adjacent. In Table 1 , we illustrate the detailed structures of 16 PAR-266
CL sites (11 on RNA 1 and 5 on RNA 2) that presented with highest consistency and average 267 PAR-CL signals (Figure 4a-d) . 268
We also noticed that the distribution of PAR-CL signals was uneven and highly clustered. 269
Numerous PAR-CL stems showed more than one PAR-CL sites with >1σ significance 270
(Supplemental data 1, 2, some examples were listed in Table 1 ). We calculated the average 271 shortest distance between adjacent PAR-CL sites. On RNA 1 (3107 nt.), among 721 uridine sites, 272
102 showed >1σ significant PAR-CL signal. The average shortest distance between these PAR-273
CL sites is 7.4 nucleotides, which is substantially shorter than the average shortest distance of 274 102 random uridines (30.47 nucleotides). On RNA 2 (1400 nt. genome with 351 uridines), the 275 average shortest distance among 45 PAR-CL sites (>1σ significance) was 8.8 nt., which is also 276
shorter than the average shortest distance of 45 random uridines (31.11 nt.). 277
Notably, by combining PAR-CL data and DMS-MaPseq-imposed RNA structure, we are able to 278 characterize a stem loop site which is structurally near identical to a previously predicted stem 279
loop (nts. 168-249) on RNA 2 (24) (Supplemental Figure S9 ). This stem loop site, as well as the 280 flanking sequence (nt. 210-249) has been determined to be essential for RNA 2 encapsidation. 281
We identified three PAR-CL signals within this region, consistent with role of this stem loop site in 282
RNA 2 packaging. 283 284 285
Structurally-disrupted PAR-CL sites impact FHV lifecycle and fitness.
To determine whether the identified PAR-CL sites have a biological function, we selected 11 PAR-287 CL sites from RNA 1 and 5 PAR-CL sites from RNA 2 as our candidate sites (Table 1) . Referring 288
to the DMS-MaPseq-corrected FHV RNA structure maps (Figure 6) , we introduced synonymous 289 mutations to disrupt the double-stranded RNA regions of the PAR-CL sites (or the nearest stem 290 of certain PAR-CL sites, i.e. U2515 on RNA1, U534, U903, U968, and U1155 on RNA2). The 291
predicted structure of these PAR-CL sites, primers, and replaced nucleotides are listed in Table  292 1. Plasmids containing these point mutations were transfected into S2 cells. Each transfection 293
consisted either a mutated RNA1 and wild-type RNA2, or a mutated RNA2 and wild-type RNA1 294 (Figure 7a) . After transfection, induction and incubation, cell viability of each transfected mutant 295
was determined with alamarBlue assay (Figure 7b) . Almost all mutant virus transfections showed 296 reduced cytopathic effect compared to transfection with wild-type FHV RNA. Notably RNA 1 297 mutants U159, and U1233 resulted in little to no detrimental effect to S2 cells. 298
Total cellular RNA was extracted from transfected cells and in-column DNase digestion was 299 conducted to remove remaining plasmids. From each transfection, 200ng of purified RNA was 300 used as template for RT-PCR to detect FHV RNA (Figure 7c ). We noticed that accumulation of 301
FHV RNA 2 was unaffected by any PAR-CL mutants, while RNA 1 accumulation varied drastically 302
among RNA 1 mutants. Notably, RNA 1 mutant U1233 yielded undetectable levels of RNA 1 and 303
RNA 3, while RNA 2 production was less affected. RNA 1 mutant U159 also produced marginal 304 amount of RNA 1 and RNA 3, and U227 produced substantially less RNA 1 than that of control 305
or RNA 2 mutants. The replication deficiency of these three mutants agreed with our findings of 306 their low virulence (Figure 7b) . Interestingly, these three sites are found within or adjacent to 307 previously described FHV RNA regulatory regions (46, 47) ( Figure 8) . The importance of these 308 three sites in both RNA-capsid interaction shown here and RNA replication regulation indicates 309 that the same motifs in the RNA genome are involved in multiple stages of the viral life-cycle, 310
consistent with the notion that replication and RNA genome packaging are tightly coupled 311
processes (20, 21) . 312
To confirm capsid production, we separated cells and supernatant from the transfected cells. 313
Western blots with anti-FHV were used to detect capsid proteins in both cellular components and 314 supernatants (Figure 7d) . In the cellular fraction, we readily detected both mature (alpha peptide) 315
and autoproteolytically cleaved capsid protein (beta peptide) in all mutants. However, reduced 316 capsid yields were found in U159 and U1233 mutants, possibly due to the observed RNA 1 317 replication deficiency. In supernatant fractions, the U159 and U1233 mutants resulted in 318 undetectable level of capsid protein, while U227 resulted in detectable but very marginal amount 319 of capsid production. This confirmed that the mutations at these three PAR-CL sites have 320 significant impact on virus production in S2 cells. 321
To expand mutant viruses, we further inoculated naïve S2 cells with equal amount of transfected 322 p0 cell mix. From the inoculated P1 cell culture, we observed different degrees of cytopathic effect 323 (CPE) under microscope (Supplemental Figure S10) , which was correlated to earlier findings.
324
P1 mutant viruses were nuclease treated, PEG precipitated, and purified with PES membrane 325 protein concentrator to remove potentially unassembled capsid subunits. The presence of virus 326
particles was confirmed with SDS-PAGE (Figure 7e) , and virus yield was calculated by 327 densitometry. Similar to before, we failed to detect virus production of U159 and U1233 mutants, 328
while U227 mutant resulted a marginal virus production which can only be detected by western 329 blot but not with SDS-PAGE. This result also agreed with our western blot analysis (Figure 7d ). 330
We further tested P1 mutant virus relative virulence by infecting cells with mutants at MOI = 1 331 (Supplemental Figure S11) . Most mutant viruses still resulted in varied but inferior virulence, in 332 comparison to wild type virus. 333
In this study, we demonstrated that PAR-CL can be used as a reliable and convenient method to 335 screen for capsid-interacting sites on viral RNA genomes. PAR-CL data analysis features low 336 background noise and thus, highly distinguishable signals. Therefore, PAR-CL signals are highly 337 specific and representative of consistent crosslinking events between virus RNA and capsid. We 338
showed that under the optimized experimental condition (4SU40h) 
PAR-CL methodology 353
Photoactivatable nucleoside analogs were successfully utilized in the past to enhance 354 crosslinking efficiency and hence, providing approaches to study RNA-RNA and RNA-protein 355
interactions (reviewed in (48)). Thionucleobases such as 4-thiouracil (4SU) and 6-thioguanosine 356 (6SG)) allows for highly effective crosslinking at 330-365 nm excitation spectrum (49), as well as 357 advantages such as minimum nucleoside structure perturbation (48, 50), lower cytotoxicity (26, 358 32, 33, 51), and less photochemistry and/or photodamage (48, 50) . Importantly, the 4SU/6SG 359 incorporated RNA can lead to specific base mismatches during reverse transcription (U-C, and 360 G-T)(27-29), which enables high-throughput screening as indications of crosslinking. This is best 361 illustrated with PAR-CLIP (PhotoActivatable-Ribonucleoside-enhanced CrossLinking and 362
ImmunoPrecipitation) technology (26), which allows for pinpointing crosslinking sites at nucleotide 363 resolution. PAR-CLIP has been successfully applied in the past to identify crosslinking sites of 364
Argonaute 2, embryonic lethal abnormal vision (ELAV) protein and pumilio homologue 2 (PUM2), 365
insulin-like growth factor proteins (26, 52). 366
As its primary purpose, PAR-CLIP was designed to screen entire transcriptome for RNA 367 sequences binding to RBP-of-interest. Typically (26, 30, 31), PAR-CLIP was conducted by 368
incubating cell cultures with 4SU, followed by 365 nm UVA irradiation, cell lysis, RNase T1 369 digestion, immunoprecipitation of RBP-of-interest, second RNase T1 digestion, de-370 phosphorylation, radiolabeling, SDS-PAGE and electro-elution, proteinase K digestion, and RNA 371 extraction. The recovered crosslinked RNA then is used as a template for cDNA library 372 preparation and deep sequencing. A natural prerequisite is large amounts of starting materials 373
(between 100-400 x 10 6 cells (30)). 374
The unique aspect of our simplified PAR-CL (PhotoActivatable-Ribonucleoside-enhanced 375
CrossLinking) method is that we applied the similar PAR-CLIP principles to an RNA virus (FHV), 376 which can be easily separated from cellular components. Crosslinks within purified virus particles 377 allow us to: (1) eliminate the need for immunoprecipitation to recover crosslinked RNA; (2) look 378
for specific in virion interactions between viral RNA genomes and viral capsid proteins; (3) study 379 a reductionist and highly controlled microenvironment. The greatly simplified PAR-CL 380 methodology, in combination with ClickSeq library construction technology (36), granted the ability 381
to conduct an experiment with as little as 2 µg of purified FHV particles. A single T25 flask of S2 382 cells can generate ample amount of pure 4SU-containing viruses to conduct multiple PAR-CL 383 experiments. 384
In our PAR-CL method, the final pool of purified viral RNA can comprise large number of wild type 385 uridines, or uncrosslinked 4SUs. As a consequence, the signal of any randomly generated, non-386 specific crosslinking event will be largely diluted into background level. Only the consistent 387 crosslinking sites present due to homogeneity in RNA-capsid interactions within a viral population 388
can readily provide distinguishable PAR-CL signals from background. Therefore, in contrast to 389 the canonical PAR-CLIP approach where only cross-linked RNA fragments are sequenced, we 390
are also able to identify regions of the viral genome where there is no reproducible PAR-CL signal, 391 either due to a lack of RNA-capsid interactions or heterogeneous interactions. This is best 392 illustrated in Figure 3b , where the background noise levels are largely unchanged, with or without 393
crosslinking. 394
In both PAR-CLIP and PAR-CL, there are intrinsic limitations of 4SU-induced crosslinking. Firstly, 395
crosslinking is only limited to U positions. Any potential interaction between protein and other 396 nucleotides is undiscoverable. Next, 4SU crosslinking with protein is affected by reactivity of 397 amino acid side chains (27, 29) , with aromatic amino acids (phenylalanine, tyrosine, and 398 tryptophan) being predominant targets but also lysine and cysteine (27). Consequentially, not all 399
RNA-protein interactions can be depicted by PAR-CL or PAR-CLIP, and certain interactions may 400 not result in crosslinking. 401
402
FHV PAR-CL experiments and data analysis 403
Several approaches were used to ensure reliable interpretation of PAR-CL signals on FHV: 1) to 404 ensure reliable interpretation of mutation rate, we limited our analysis to genomic positions with 405 at least 10k coverage. For this reason, our FHV PAR-CL experiments reliably covered U34 -406 U3034 on RNA 1, and U9 -U1337 on RNA 2. However, it is possible that we omitted potential 407 capsid interaction sites out of our analyzed range. 2) We previously noticed that certain point 408 mutations may be selected by virus and could be associated with defective interfering RNA 409 generation (34). In this study, we also noticed substantially increased mutation rates on certain 410
genomic positions (such as U1259 on RNA1, as illustrated in Figure 2a-c) . Thus, to eliminate 411 virus intrinsic mutational events, we avoided to use U-C mutation rate as a measurement. Instead, 412
we decided to use fold change of U-C mutation rate, between crosslinked virus and uncrosslinked 413 virus control, as our PAR-CL signals. 3) Because our PAR-CL signal corresponds to the fold 414 change of U-C mutation rates of two datasets, a substantial PAR-CL signal can be a consequence 415 of three scenarios: a high U-C rate in crosslinked virus, a much lower U-C rate in uncrosslinked 416
control, or both. To minimize the possibility of false positives, we introduced a background 417 threshold. Only the PAR-CL signals above this threshold were taken into our further consideration, 418
as they represent mutation rates distinguishable from background fluctuation range (illustrated in 419
Supplemental data 3). Together, we believe these three quality control measurements provided 420 stringent analysis to our PAR-CL data to reveal truly biologically relevant FHV RNA-capsid 421 interaction sites. 422
423
DMS-MaPseq and FHV secondary structure mappings 424
Several studies have proposed lowest free energy-based FHV local or whole genome secondary 425 structure predictions, with the focus on viral RNA intracellular arrangement and replication 426
regulations (24, 46, 47, 53) . In vivo RNA chemical probing methods such as DMS and SHAPE 427 allow for structure-specific chemical modifications to be screened by next generation sequencing 428
techniques (40, 54, 55) . Using DMS-MaPseq in authentic FHV virions, we are able to provide 429 experimental validation of the RNA structures inside virus particles. With the same rationale of 430 PAR-CL, we also applied stringent quality control measurements to ensure reliable interpretation 431 of mutational profiles generated by DMS-MaPseq: A/C error rates were only analyzed over 432 positions with at least 10k coverage (A14-A3043 on RNA 1, and C11-A1378 on RNA 2); fold 433 change of A/C mutation rate was regarded as DMS-MaPseq signals instead of actual mutation 434 rate; similar background noise threshold was also applied to prevent potential false positives. 435
Canonically, DMS-MaPseq data is imposed upon thermodynamic prediction by enforcing 436 unpaired constraints on any position with a signal above a given threshold (40) . In this study, we 437 adjusted this approach by only allowing the most significant (top 5%) DMS-MaPseq signals to be 438 unpaired constraints. However, in this study, we constructed FHV secondary structural maps over 439
RNA 1 and RNA 2 separately, omitting potential inter-RNA interactions. 440
Combining PAR-CL and DMS-MaPseq, we demonstrated that these two high-throughput 441 mutational profile technologies can work synergistically to answer basic virology questions. We 442 observed that the FHV RNA-capsid sites heavily favored double stranded RNA structures. This 443
finding agreed with earlier predictions that the RNA duplexes scaffold the 2-fold axis of FHV 444 capsid (12). 445 446
Flock house virus PAR-CL sites and biological indications 447
It has been observed previously that the RNAs of FHV, as well as other Nodaviruses, form a 448 highly ordered dodecahedral cage inside virus particles (10, 56). However, it was not clear 449
whether the dodecahedral RNA cage had a fixed topology. From our PAR-CL data (Figure 4a-d) , 450
we can clearly identify highly consistent RNA-capsid interactions over certain genomic positions 451 among multiple replicate experiments. This provides evidence that there is well-defined tropism 452 between FHV RNA cage and capsid shell, at least at a these sites identified here. Among the 453 most consistent and distinguished PAR-CL sites (Figure 4c, d) , we noticed that they exhibited a 454
highly clustered pattern. The clustering effect is more pronounced, when taking RNA secondary 455 structures into consideration (Figure 6 and Supplemental data 1, 2) . 456
The multiple RNA-capsid interaction sites spanning the whole FHV genome suggest the 457 possibility that FHV encapsidation may require multiple packaging signals to assembly the entire 458 virus genome. Flock House virus genome packaging process may be similar to the two-staged 459
packaging mechanism of MS2 bacteriophage (57). Numerous synergetic high-affinity RNA-capsid 460 interaction sites are required to recruit capsid subunits. These widely-distributed interaction sites 461 facilitate capsid-capsid interactions, which reciprocally mediate RNA folding and tertiary 462 compression of RNA genome. Subsequently, this can be followed by continuous recruitment of 463 capsids on folded RNA to finalize encapsidation process. 464
Several PAR-CL sites also aligned with, or in close adjacent to, known RNA motifs (Figure 8) . 465 On RNA 1 (Figure 8a) , we could not align any candidate PAR-CL signal to subgenomic RNA 3, 466
which suggests the possibility that the exclusion of RNA 3 during packaging is due to lack of 467 strong RNA-capsid interactions. Interestingly, two most significant PAR-CL sites on RNA 1, U159 468
and U1233, aligned with previously discovered replication regulatory elements: a 5' cis element 469
(nts. 68-205) that is essential for RNA 1 replication and mitochondria-targeting(46), and short 470 distal subgenomic control cis-element (nts. 1229-1239) which mediates subgenomic RNA 3 471 replication (47). Furthermore, U2515 and U2576 were located in the subgenomic promoter region 472
(47, 58) which are also adjacent to a RNA 1 internal cis-acting replication element (intRE, nts 473 2322-2501) (47). Similarly, on RNA 2 (Figure 8b) , we noticed PAR-CL site U534 is adjacent to a 474
RNA 2 cis-acting regulatory site (59), and U1155 which is within a site required for specific 475 packaging of both RNAs (18). A previously predicted stem loop site (nts 168-249) on RNA 2 476 serves as a RNA 2 packaging signal (24). This is also the only established FHV RNA packaging 477 signal to date. Our DMS-MaPseq map did predict near identical stem loop structure as previous 478
proposed and we noticed three significant (>1σ) PAR-CL sites were clustered in this critical region 479 (Supplemental Figure S9 ). Since these RNA-capsid interaction sites are correlated to RNA 480 cellular replication/mitochondrial targeting sites, we suggest they might be multi-functional in virus 481 life cycle, and there can be a strong synergy between protein A-mitochondria localization (9, 60, 482 61), RNA replication, and virus assembly. 483
It was speculated previously that FHV packaging and replication are coordinated events. When 484 FHV and brome mosaic virus (BMV) were co-expressed in plant cells, assembled virions only 485 packed their own respective viral RNAs (20). Intracellular protein-protein interactions between 486
FHV replicase (protein A) and capsid were detected (21). It has also been shown that FHV can 487 ensure genome assembly specificity only when capsids were translated from replicating viral 488
RNAs (23). It was hence suggested that FHV encapsidation may be coupled with the RNA 489
replication. Our FHV PAR-CL experiments directly implicated only one aspect of FHV biology: the 490 RNA sites interacting with capsid proteins. However, upon further analysis and mutational assays, 491 a number of PAR-CL sites clearly indicated their significance in FHV replication and regulation: 492 U159 and U227 mutants showed severe deficiency of RNA 1 replication and virion production, 493
while U1233 entirely abolished viral replication. This provides further evidence that FHV 494 replication and packaging are not sequentially separated events, but rather a synchronized, highly 495
inter-dependent processes. Furthermore, these RNA-capsid interactions are not only important in 496 post-replicational/translational RNA packaging, but may also be essential for multiple aspects of 497 virus early stage activities in host cells. 498 Cell culture and virus 500 D. melanogaster (S2) cells were regularly maintained and passaged with Schneider's Drosophila 501
Media (Gibco) containing 10% fetal bovine serum, 1 × Antibiotic-Antimycotic (Gibco), 1 × MEM 502 non-essential amino acids solution, and 1 mM sodium pyruvate. 503
As described previously (34), wt Flock House virus (FHV) was generated by transfecting S2 cells 504
with pMT plasmid vectors (Invitrogen) containing respective genomes (NC_004146 for RNA 1, 505
and NC_004144 for RNA 2). Copper sulfate was used to induce the promoter 24 h post 506 transfection, while viruses were allowed to accumulate until 3 days post induction to yield passage 507 0 (p0) virus/cell mixture. The p0 transfected cells and viruses were then used to inoculate naïve 508 S2 cells in a T75 flask for 3 days to yield passage 1 viruses, which were purified and used as FHV 509
inoculum in this study, unless otherwise mentioned. 510
All virus transfections, infections, and passages with S2 cell culture were maintained in 27°C 511
incubator, unless otherwise mentioned. 512
To purify FHV, 1% Triton X-100 was added to the cell culture containing p1 viruses. Cell culture 513 underwent one freeze-thaw cycle, and cell debris was removed with 3000 × g centrifugation. FHV 514
in the supernatant was crudely purified with 4% polyethylene glycol (PEG) 8000 and centrifuged 515
(6000 × g) to remove debris (8). This was followed by DNase I and RNase A overnight digestion, 516
to remove any co-precipitated cellular DNA or RNA. Unless otherwise mentioned, viruses were 517
further purified with a 10-40% sucrose gradient, and ultracentrifuge at 40,000 RPM for 1.5 h. 518
Viruses were then concentrated with 100K MWCO polyethersulfone (PES) membrane protein 519 concentrator (Pierce) and washed three times with 10mM Tris pH 7.4. 520
521
PAR-CL and ClickSeq 522
S2 cells were maintained in T75 flask until 70% -90% confluency. Cells were infected with purified 523
Flock House virus (p1) at MOI = 1 (34, 62, 63). As an initial dose, 4-thiouridine (Sigma-Aldrich) 524
was supplemented to the cell culture to 100µM as 1 × concentration with virus. An optional "boost" 525 dose of 4-thiouridine can also be supplied 16 h post infection (Figure 3a) . Cells and viruses were 526 harvested at 16 or 40 h post infection (Figure 3a) . Viruses were purified with methods described 527
above. 528
The nuclease-treated and purified 4SU-containing viruses were placed uncovered over ice and 529 irradiated with 0.15 J/cm 2 (26, 30) Equal molar of each indexed library was pooled and run on a HiSeq 1500 platform (Illumina), with 540 single read rapid run flowcell for 1x150 reads and 7 nucleotides for the index. 541
542
DMS-MaPseq and ClickSeq 543
Dimethyl sulfate (DMS) RNA methylation method was described previously (40, 42) . In this study, 544
nuclease-treated and purified FHV was supplemented with DMS to 5% final concentration. After 545 5 min incubation at 30°C, reaction was quenched on ice for 5 min with 2 volumes of 10mM Tris 546 pH 7.4 and 30% 2-Mercaptoethanol (BME). RNA extraction was conducted with Quick-RNA Viral 547
Kits (Zymo Research) with additional BME in the extraction buffer. The DMS-control sample 548 comprises the same virus stock with identical treatments as above, but without DMS supplement. 549
Methylated FHV RNA and respective controls were proceeded with similar ClickSeq library 550 construction method. One exception is the use of a high-fidelity and processive thermostable 551 group II reverse transcriptase enzyme (TGIRT-III, InGex) during reverse transcription. 100U of 552
TGIRT-III was mixed with 250ng of RNA template, 0.5mM of AzNTPs/dNTPs mixture 553
(AzNTPs:dNTPs = 1:35), and the following reaction conditions: 5 mM Dithiothreitol (Invitrogen), 554
10 U RNaseOUT (Invitrogen), 50 mM Tri-HCl pH 8.0, 75 mM KCl, and 3 mM MgCl2. The reaction 555 mix was incubated in room temperature for 10 min, followed by 57°C incubation for 1.5 hrs, and 556
75°C termination for 15 min. The terminated reaction was then digested with RNase H to remove 557
RNA template. The purified cDNA was proceeded with click reaction with Illumina adapters and 558
final PCR amplification with indexes. 559
Library pooling and Illumina sequencing platform are the same as above. 560 561
Bioinformatics and data analysis 562
The Illumina sequencing data of both PAR-CL and DMS-MaPseq were subjected to the following 563 bioinformatic pipelines: first the Illumina sequencing adapter sequence "AGATCGGAAGAGC" 564 was trimmed with cutadapt (37) (command line parameters: -b AGATCGGAAGAGC -m 40); then, 565
we used FASTX toolkit (http://hannonlab.cshl.edu/fastx_toolkit/index.html) to remove the 566 remaining random nucleotides from the Illumina adapter sequence and random base-pairing as 567 a result of azide-alkyne cycloaddition from cDNA fragments (command line parameters: 568
fastx_trimmer -Q33 -f 7); a further quality filter was applied to remove any reads that contained 569 more than 4% nucleotides with a PHRED score <20 (command line parameters: 570
fastq_quality_filter -Q33 -q 20 -p 96). The remaining reads were aligned to FHV genomes 571 (NC_004146, and NC_004144). Data generated from PAR-CL experiments were aligned for end-572
to-end matches with Bowtie (v1.0.1) (38) (command line parameters: -v 2 --best). Data generated 573 from DMS-MaPseq experiment were aligned with Bowtie2 (64) to allow longer and gapped 574 alignments (command line parameters: --local). Using SAMtools (65), the aligned reads were 575 binarily converted, merged, indexed, sorted, and mathematically noted. 576
For both PAR-CL and DMS-MaPseq, we excluded any nucleotide location with less than 10k 577 coverage to ensure reliable mutation rate calculation. For PAR-CL, we calculated the mutation 578 frequencies of each of the four nucleotides, as well as the U-C mutation rate at each genomic U 579 position. For DMS-MaPseq, similar analysis was conducted but we focused on the overall 580 mutation rates of A and C genomic positions. Between test group and respective control 581 (4SU+/UV+ and 4SU+/UV-for PAR-CL, DMS+ and DMS-for DMS-MaPseq), we compared the 582 mutation rate at the same genomic position, to yield the fold change map, as presentations of 583 PAR-CL or DMS-MaPseq signals. . U-C mutation rate elevation is specific to 4SU crosslink. Using FHV RNA 1 as an example, several control experiments were conducted to ensure specificity of PAR-CL signals. (a) effects of UV exposure to wt FHV (4SU-) were compared. We did not observe significant U-C mutation rate elevation. (b) effects of 4SU incorporation were compared to FHV without UV exposure (UV-). We did not observe significant U-C mutation rate elevation. (c) only when 4SUcontaining FHV was irradiated with UV, we observed a significant increase in U-C mutation rates. (a-c) orange line represents the average fold change in each experiment. (d) the distribution of U-C mutation frequency: only when both 4SU and UV both presented, did we notice a shift towards higher U-C mutation rates.
(e) crosslink did not impact the rates of other mutations (A,G,C-mutations, or U-A/U-G mutations). Using FHV RNA 1 as an example, (a) three experimental conditions were tested for impact to PAR-CL signals. We observed that the intensities of PAR-CL signals (i.e. fold change of U-C mutation rate) were related to the concentration of 4SU in cell culture and the time of incubation. (b) with or without crosslink, the average PAR-CL signals among all 4SU-containing FHVs is similar. However, the outliers of crosslinking groups showed a significant higher PAR-CL signals than that of control (4SU+,UV-), and the magnitude of outliers correlated with 4SU concentration and incubation time. (c) We sampled top 5% PAR-CL signals from three experiment groups and determined that optimal PAR-CL signal was achieved under 4SU40h condition, which was applied to all further PAR-CL experiments. . (c, d) Triplicated PAR-CL signals of FHV RNA 1 and 2 were box-plotted. We removed any PAR-CL signal failed to pass the background threshold. A number of sites on both RNA 1 and RNA 2 showed consistently significant PAR-CL signals, indicating reliable crosslinking sites between RNA and protein. These consistent PAR-CL sites also suggest a strong tropism of FHV RNA cage inside virion. X-axis is not continuous. (e) Among these consistent PAR-CL sites, most of them showed significantly higher PAR-CL signals than the average. *P<0.05; **P<0.01; NS=not significant. . Snapshots of RNA 1 (left) and RNA 2 (right) are shown. Full scaled maps can be found in Supplementary data 1 and 2. PAR-CL signal sites of different significance were color annotated. The introduced DMS-MaPseq constraints were highlighted by lower case "a" or "c" in red color. Figure 7 . FHV PAR-CL mutants characterization. (a) Plasmids containing FHV RNA 1 or RNA 2 with mutated PAR-CL structures were transfected to S2 cells to yield p0 mutant viruses. (b) Relative virulence of p0 mutant viruses was determined with alamarBlue assay to measure cell viability after transfection. (c) 200ng of total cellular RNA of each transfection was analyzed with RT-PCR to measure the accumulation of FHV RNAs. (d) Cellular and supernatant FHV capsid productions were detected with anti-FHV antibodies. Coomassie-stained α-tubulin as loading control for cellular assay. (e) p1 viruses were purified and filtered with 100 K molecular weight filter, mutant virus production was verified with SDS-PAGE gel. Heat shock protein 70 (hsp70) shown as a loading control. (a) On RNA 1, four highly conserved defective interfering RNA regions (DI regions 1-4)(34) were shown in pink; four RNA 1 replication regulatory elements were shown in orange (5'Cis (46), 5'intRE(47), 3'intRE(47), and (67)); two RNA 3 regulatory elements and a putative RNA 3 subgenomic promoter region were shown in green (RNA3cis(dis) (47), RNA3cis(prox)(47)); the candidate PAR-CL sites (listed in Figure 4e ) were shown as red bars on bottom. (b) On RNA 2, three conserved defection interfering RNA regions were shown in pink (DI regions 1-3 (34)); a mid-genome cis-acting replicational element(59) and a 3' cis-acting regulatory element(67) were shown in brown; a RNA 2 packaging signal (24) and a capsid site essential for RNA 1&2 specificity (18) are shown in green.
